Jeffrey Karp

Jeff Karp
Jeffrey Karp
Residence	United States
Nationality	Canada
Fields	Bioinspired medical problem solver, Tissue adhesives, Biomedical engineering, Mesenchymal stem cell therapy
Institutions	Harvard Medical School, Massachusetts Institute of Technology
Alma mater	McGill University, University of Toronto, Massachusetts Institute of Technology
Doctoral advisor	John Davies & Molly Shoichet
Other academic advisors	Robert S. Langer

Jeff Karp is a Canadian–born biomedical engineer. He is an Associate Professor of Medicine at Harvard Medical School, Brigham and Women's Hospital, and the principal faculty at the Harvard Stem Cell Institute and Affiliate Faculty at the Massachusetts Institute of Technology through the Harvard–MIT Division of Health Sciences and Technology. He is also an affiliate faculty at the Broad Institute.

Karp has co-founded four medical companies, including Skintifique, which develops products for those with skin ailments or damaged/sensitive skin, Gecko Biomedical which develops hydrophobic light-activated adhesives (a type of surgical glue intended to augment or replace sutures), Alivio Therapeutics, which develops inflammation targeting and inflammation responsive materials for treating inflammatory diseases, and Frequency Therapeutics, which focuses on medical treatment for chronic hearing loss. In 2008 MIT's Technology Review listed him as one of the top innovators in the world under the age of 35 (TR35).

Jeff was born and raised in Peterborough, Ontario, graduating from Crestwood Secondary School. He graduated from McGill University in 1999 with a degree in chemical engineering. At McGill he was elected to the McGill Senate to represent over 2000 students, he was also a nominated member of the McGill Admissions Committee, the Advisory Committee to Select a new dean of Engineering, and the Student Affairs Senate Sub-Committee. While at McGill he also co-founded the McGill Engineering Code of Ethics "The Blueprint".

...
Wikipedia